<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03996382</url>
  </required_header>
  <id_info>
    <org_study_id>1-10-72-330-18</org_study_id>
    <nct_id>NCT03996382</nct_id>
  </id_info>
  <brief_title>Prevalence of Wild Type Transthyretin Cardiac Amyloidosis in Patients Operated for Idiopathic Carpal Tunnel Syndrome</brief_title>
  <acronym>CACTuS</acronym>
  <official_title>Prevalence of Wild Type Transthyretin Cardiac Amyloidosis in Patients Operated for Idiopathic Carpal Tunnel Syndrome</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Aarhus University Hospital Skejby</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Regional Hospital Holstebro</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Aarhus University Hospital Skejby</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Wild-type transthyretin cardiac amyloidosis is an underdiagnosed depository disease in which&#xD;
      fibril monomers of misfolded amyloid protein accumulates in various tissues, including the&#xD;
      heart, and cause tissue dysfunction.&#xD;
&#xD;
      Before onset of cardiac symptoms, many patients will have undergone surgery for idiopathic&#xD;
      carpal tunnel syndrome since the protein also deposits in the transversal carpal ligament of&#xD;
      the hand.&#xD;
&#xD;
      This study investigates patients previously operated for idiopathic carpal tunnel syndrome to&#xD;
      determine if they display signs and symptoms of cardiac amyloidosis.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">June 17, 2019</start_date>
  <completion_date type="Actual">December 1, 2020</completion_date>
  <primary_completion_date type="Actual">December 1, 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Prevalence of cardiac amyloidosis.</measure>
    <time_frame>Through study completion, an average of 2 years.</time_frame>
    <description>The prevalence of cardiac amyloidosis among patients previously operated for ipiopathic carpal tunnel syndrome.</description>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">120</enrollment>
  <condition>Amyloidosis Cardiac</condition>
  <condition>Carpal Tunnel Syndrome</condition>
  <arm_group>
    <arm_group_label>Suspicion of cardiac amyloidosis</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Patients who display signs of cardiac amyloidosis will be referred for further diagnosis.</description>
  </arm_group>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>DPD Scintigraphy</intervention_name>
    <description>Confirms/Refutes diagnosis of cardiac amyloidosis.</description>
    <arm_group_label>Suspicion of cardiac amyloidosis</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Patients above sixty years of age previously operated for idiopathic carpal tunnel&#xD;
             syndrome within the Region of Central Denmark (Region Midtjylland) the last five&#xD;
             years.&#xD;
&#xD;
          -  Informed written and verbal consent&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Operation by different indication such as&#xD;
&#xD;
               -  Fracture&#xD;
&#xD;
               -  Ganglion&#xD;
&#xD;
               -  Tumors&#xD;
&#xD;
               -  Osteophytes&#xD;
&#xD;
               -  Rheumatoid Arthritis&#xD;
&#xD;
               -  Persistent medial artery&#xD;
&#xD;
               -  Metabolic causes&#xD;
&#xD;
          -  Alcoholism&#xD;
&#xD;
          -  Hyperthyroidism&#xD;
&#xD;
          -  Myxedema&#xD;
&#xD;
               -  Hereditary Cardiac Amyloidosis&#xD;
&#xD;
               -  Known WT ATTR&#xD;
&#xD;
               -  AL Amyloidosis&#xD;
&#xD;
               -  Myelomatosis&#xD;
&#xD;
               -  MGUS and Morbus Waldenstr√∂m&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>60 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Department of Heart Disease</name>
      <address>
        <city>Aarhus</city>
        <zip>8200</zip>
        <country>Denmark</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Denmark</country>
  </location_countries>
  <verification_date>October 2021</verification_date>
  <study_first_submitted>June 17, 2019</study_first_submitted>
  <study_first_submitted_qc>June 21, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">June 24, 2019</study_first_posted>
  <last_update_submitted>October 1, 2021</last_update_submitted>
  <last_update_submitted_qc>October 1, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">October 8, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Aarhus University Hospital Skejby</investigator_affiliation>
    <investigator_full_name>Steen Hvitfeldt Poulsen</investigator_full_name>
    <investigator_title>Professor</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Carpal Tunnel Syndrome</mesh_term>
    <mesh_term>Amyloidosis</mesh_term>
    <mesh_term>Syndrome</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

